InMed Pharmaceuticals Inc. (INM) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.82M | -2.17M | -736.68K | -1.65M | -2.71M | -2.26M | -3.99M | -5.27M | -3.53M | -2.65M | -2.2M |
| Operating CF Margin % | -0.27% | -286.73% | -200.17% | -100.08% | -131.54% | -225.07% | -144.45% | -80.21% | -164.96% | -146.53% | -241.08% | -24.06% | -160.04% | -426.55% | -509.08% | -774.99% | -1703.7% | -1053.8% | - | - |
| Operating CF Growth % | -6% | -28.96% | -22.74% | -72.81% | 14.21% | -37.69% | 15.98% | -39.7% | -16.9% | 33.02% | 3.61% | 81.53% | 68.63% | 23.2% | 15.01% | -81.54% | -14.37% | -96.1% | -93.49% | -76.69% |
| Net Income | -2.79M | -3.75B | -2.41M | -1.79M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -338.39K | -2M | -2.1M | -3.51M | -7.87M | -3.48M | -4.28M | -2.97M | -3.26M |
| Depreciation & Amortization | 134.66K | 314.54M | 218.53K | 131.08K | 129.58K | 129.08K | 144.98K | 151.86K | 150.69K | 148.32K | 149.36K | 150.13K | 142.62K | 147.36K | 148.51K | 144.52K | 142.79K | 138.06K | 28.53K | 39.31K |
| Stock-Based Compensation | 0 | 45.45M | 20.2K | 26.73K | 40.45K | 23.16K | 28.96K | 38.95K | 55.3K | 0 | 25.19K | 0 | 0 | 70.64K | 116.68K | 0 | 0 | 0 | 111.14K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 94.95K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.26K | 0 |
| Other Non-Cash Items | -244.87K | 3.39B | 1.89K | 32.88K | 25.98K | 14.71K | 4.75K | 52.08K | 1.38K | 217.66K | -538 | -394.61K | -44.77K | 125.06K | 579.45K | 4.99M | 162.06K | 131.56K | 8.47K | -15.13K |
| Working Capital Changes | 1.14M | -821.01K | -82.23K | -180.88K | 265.42K | -94.06K | -327.64K | 665.61K | -418.82K | -705.04K | 93.65K | -153.81K | 245.43K | -955.06K | 410.02K | -1.25M | -2.1M | 480.68K | 168.29K | 1.04M |
| Change in Receivables | 0 | 217.12K | 170.38K | -99.72K | -105.24K | 22.13K | 68.14K | -145.16K | 165.19K | -206.16K | 94.55K | -112.8K | -87.43K | -91.56K | 72.86K | -17.28K | -20.1K | 638 | -2.92K | 60.77K |
| Change in Inventory | 0 | -173.91K | 98.14K | -147.2K | 289.39K | 116.72K | 24.25K | -92.78K | -449.11K | 213.12K | 390.33K | -11.45K | 280.75K | 165.02K | 135.56K | -1.06M | -425.54K | 0 | 0 | 0 |
| Change in Payables | 110.28K | -77.25K | -382.25K | 0 | 0 | 0 | 0 | 0 | 0 | 243.84K | -375.06K | -227.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | -2 | -9.22K | 0 | -41.15K | -128.57K | -500K | 0 | -719.34K | -3.88K | 306K | -250K | -1.8K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88 | -2 | -9.22K | 0 | -159.6K | 0 | 0 | 0 | 79 | -3.3K | -35.55K | 0 | -1.8K |
| CapEx % of Revenue | 0% | 0% | - | - | - | - | - | 0.01% | 0% | 0.74% | - | 5.21% | 0% | - | - | 0.02% | 1.07% | 10.6% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 490.38K | -490.38K | 0 | 90.78K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118.45K | -618.94K | -9.62K | 0 | -297.88K | 0 | 250K | -250K | 0 |
| Cash from Financing | 231.48K | 1.16K | -191.33K | 8.17M | 2.92M | 338.52K | 838.24K | 176 | 0 | 4.62M | 0 | 129.7K | -14.24K | 5.32M | 5.43M | 4.99M | -92.93K | -838.25K | 10.88M | 55.42K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 393.68K | -24.95K | -657.06K | 0 | 0 |
| Equity Issued (Net) | 231.48K | 1.16K | -191.33K | 3.77M | 2.94M | 396.15K | 1.03M | -43.83K | 0 | 4.62M | 0 | 129.7K | -14.24K | 4.74M | 6M | 4.59M | -67.98K | -181.18K | 12M | 55.42K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 4.41M | -15.1K | -57.63K | -191.82K | 44K | 0 | 0 | 0 | 0 | 0 | 571.26K | -571.26K | 0 | 0 | 0 | -1.12M | 0 |
| Net Change in Cash | -1.8M | -3.26M | -2.43M | 6.4M | 1.26M | -2.16M | -988.57K | -1.03M | -1.93M | 2.8M | -2.17M | -691.54K | -1.85M | 2.1M | 3.17M | 278.55K | -5.38M | -4.06M | 7.98M | -2.09M |
| Free Cash Flow | -1.76M | -3.23M | -2.24M | -1.78M | -1.66M | -2.5M | -1.83M | -1.03M | -1.93M | -1.83M | -2.17M | -896.29K | -1.65M | -2.71M | -2.26M | -3.99M | -5.28M | -3.57M | -2.65M | -2.2M |
| FCF Margin % | -0.27% | -286.73% | -200.17% | -100.08% | -131.54% | -225.07% | -144.45% | -80.21% | -164.96% | -147.27% | -241.08% | -29.28% | -160.04% | -426.55% | -509.08% | -774.98% | -1704.77% | -1064.41% | - | - |
| FCF Growth % | -5.99% | -28.96% | -22.74% | -72.81% | 14.21% | -36.99% | 15.98% | -14.82% | -16.9% | 32.68% | 3.61% | 77.53% | 68.65% | 23.96% | 15.01% | -81.39% | -14.44% | -98.08% | -93.49% | -77.07% |
| FCF per Share | -0.43 | -816.10 | -567.07 | -0.89 | -1.51 | -3.54 | -2.95 | -2.31 | -4.02 | -4.58 | -13.07 | -5.39 | -9.94 | -23.59 | -52.12 | -111.46 | -186.47 | -128.84 | -110.14 | -136.59 |
| FCF Conversion (FCF/Net Income) | 0.59x | 1.16x | 1.30x | 0.73x | 0.78x | 0.97x | 1.09x | 0.53x | 1.12x | 1.23x | 0.86x | 1.64x | 0.83x | 0.95x | 0.47x | 0.51x | 1.52x | 0.65x | 0.89x | 0.67x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.1K | 0 | 0 | 0 | 0 | 0 | 3K | 6.8K | 0 | 0 | 0 | 0 | 0 |